NE1 Inc.
Biotechnology company · New York, United States
NE1 Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2020. It has received 1 NIH small-business research grant, $388,656 in total.
Profile compiled from public records. Is this your company? Request a correction or update
NE1 at a glance
Typebiotechnology company
HeadquartersNew York, United States
Earliest incorporation on record2020
SEC CIK1884684
What does NE1 do?
US government research funding
1 NIH small-business research grant, $388,656 in total. NIH funding came from the National Cancer Institute.
Frequently asked questions about NE1
Where is NE1 headquartered?
NE1 Inc. is headquartered in New York, United States.
What does NE1 do?
NE1 Inc. is a biotechnology company.
When was NE1 founded?
The earliest incorporation on record for NE1 Inc. is in 2020, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences